Test Questions

The Treatment of Benign Prostatic Hyperplasia

Exam Questions

1. It is estimated that, by the age of 70, ______% of men experience symptoms of benign prostatic hyperplasia (BPH).
    A. 20
    B. 40
    C. 60
    D. 80
2. Which of the following is not a sign or symptom of BPH?
    A. Diminished urine stream
    B. Abdominal pain
    C. Nocturia
    D. Difficulty beginning urination
3. BPH may present clinically in a manner similar to:
    A. Prostatitis
    B. Prostate cancer
    C. Urinary tract infection
    D. All of the above
4. A score of 8 on the Symptom Score Index (SSI) indicates that a patient has:
    A. Mild BPH
    B. Moderate BPH
    C. Severe BPH
    D. A medical emergency requiring surgery
5. The main reason for treating BPH is to:
    A. Relieve or prevent symptoms
    B. Remove the prostate gland
    C. Prevent prostate cancer
    D. All of the above
6. In order to assist the patient who has urinary symptoms, the pharmacist can recommend that:
    A. Diuretics be taken in the morning instead of at night
    B. Beverages be avoided close to bedtime
    C. Caffeine-containing products be consumed earlier in the day
    D. All of the above
7. A patient presenting with an SSI of 3 and not requesting any medication should be:
    A. Closely followed to make sure symptoms do not worsen
    B. Started on a low-sodium diet
    C. Started on an alpha-adrenergic antagonist
    D. Started on a 5-alpha-reductase (5-AR) inhibitor
8. Phenoxybenzamine is no longer used for the treatment of BPH because of its adverse side-effect profile including:
    A. Orthostatic hypotension
    B. Reflex tachycardia
    C. Cardiac arrhythmias
    D. All of the above
9. The American Urological Association Practice Guidelines Committee concluded that existing data are insufficient to determine whether which of the following is effective for treating lower urinary tract symptoms secondary to BPH?
    A. Alfuzosin
    B. Doxazosin
    C. Prazosin
    D. Terazosin
10. Which of the following should be avoided in a patient with a sulfa allergy?
    A. Alfuzosin
    B. Doxazosin
    C. Prazosin
    D. Tamsulosin
11. Which of the following have become first-line agents in the treatment of BPH due to their rapid onset of action and their proven safety and efficacy?
    A. Alpha-adrenergic antagonists
    B. 5-AR inhibitors
    C. Cyclo-oxygenase-2 inhibitors
    D. None of the above
12. What is the role of 5-AR in relation to testosterone?
    A. It induces the conversion of dihydrotestosterone (DHT) to testosterone
    B. It inhibits the conversion of DHT to testosterone
    C. It induces the conversion of testosterone to DHT
    D. It inhibits the conversion of testosterone to DHT
13. Women who are or may become pregnant should not handle crushed or broken tablets of which of the following, as the drug is a Pregnancy Category X medication?
    A. Alfuzosin
    B. Doxazosin
    C. Finasteride
    D. Tamsulosin
14. A study concluded that patients who would receive the most benefit from the combination of a 5-AR inhibitor and an alpha-1 adrenergic-receptor antagonist are those with:
    A. A large prostate
    B. Severe symptoms
    C. High prostate-specific antigen (PSA) levels
    D. All of the above
15. Surgery for BPH is usually reserved for patients with:
    A. Mild cases
    B. Moderate cases
    C. Severe cases
    D. None of the above, as surgery is never performed for BPH
16. Which of the following medications has been used extensively in the United States because of its low incidence of sexual side effects and long half-life allowing once-daily dosing?
    A. Alfuzosin
    B. Doxazosin
    C. Prazosin
    D. Terazosin
17. In human prostate cells, the ______ type is the most prevalent.
    A. Alpha-1a receptor
    B. Alpha-1b receptor
    C. Beta-1a receptor
    D. Beta-1b receptor
18. BPH most correctly stands for:
    A. Benign prostatic hypotrophy
    B. Benign prostatic hypoplasia
    C. Benign prostatic hypertrophy
    D. Benign prostatic hyperplasia
19. In patients with BPH, PSA monitoring and digital rectal examination should be performed:
    A. Every three months
    B. Every four months
    C. Every six months
    D. Annually
20. Which of the following does not belong with the others?
    A. Alfuzosin
    B. Dutasteride
    C. Prazosin
    D. Terazosin

Evaluation Questions

21. Met objective 1:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
22. Met objective 2:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
23. Met objective 3:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
24. Met objective 4:*
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
25. Related to your practice needs:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
26. Will help you improve patient care:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
27. Avoided commercial bias:
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
28. How would you rate the overall quality of the material presented?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
29. How would you rate the overall user friendliness of the program?
    A. Excellent
    B. Very Good
    C. Good
    D. Fair
    E. Poor
30. Comments on this program:
 
* Also applies to pharmacy technicians